Nisa Investment Advisors, LLC Intra Cellular Therapies, Inc. Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 4,168 shares of ITCI stock, worth $303,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,168

Previous 4,305 3.18%

Holding current value

$303,680

Previous $297,000 4.04%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$64.76 - $79.84 $8,872 - $10,938	-137 Reduced 3.18%	4,168 $285,000
Q1 2024 May 01, 2024	BUY	$64.37 - $75.65 $4,699 - $5,522	73 Added 1.72%	4,305 $297,000
Q4 2023 Jan 25, 2024	SELL	$46.37 - $73.65 $8,810 - $13,993	-190 Reduced 4.3%	4,232 $303,000
Q3 2023 Nov 02, 2023	SELL	$52.09 - $64.1 $791,768 - $974,319	-15,200 Reduced 77.46%	4,422 $230,000
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $829,890 - $1.01 Million	15,180 Added 341.74%	19,622 $1.24 Million
Q1 2023 May 02, 2023	SELL	$43.8 - $56.99 $876 - $1,139	-20 Reduced 0.45%	4,442 $241,000
Q3 2022 Nov 07, 2022	BUY	$42.7 - $59.99 $15,841 - $22,256	371 Added 9.07%	4,462 $205,000
Q2 2022 Aug 03, 2022	SELL	$43.0 - $65.64 $22,360 - $34,132	-520 Reduced 11.28%	4,091 $234,000
Q1 2022 Apr 29, 2022	SELL	$38.74 - $62.09 $164,954 - $264,379	-4,258 Reduced 48.01%	4,611 $282,000
Q4 2021 Feb 03, 2022	BUY	$35.2 - $53.42 $1,654 - $2,510	47 Added 0.53%	8,869 $421,000
Q3 2021 Oct 18, 2021	BUY	$28.72 - $42.49 $3,503 - $5,183	122 Added 1.4%	8,822 $329,000
Q4 2020 Jan 25, 2021	BUY	$23.34 - $32.22 $28,591 - $39,469	1,225 Added 16.39%	8,700 $277,000
Q3 2020 Oct 20, 2020	SELL	$17.61 - $31.86 $50,135 - $90,705	-2,847 Reduced 27.58%	7,475 $192,000
Q2 2020 Jul 27, 2020	BUY	$14.35 - $26.64 $6,773 - $12,574	472 Added 4.79%	10,322 $265,000
Q1 2020 Apr 17, 2020	BUY	$12.31 - $33.12 $5,785 - $15,566	470 Added 5.01%	9,850 $151,000
Q3 2019 Oct 17, 2019	BUY	$7.47 - $14.03 $70,068 - $131,601	9,380 New	9,380 $70,000

Others Institutions Holding ITCI

# of Institutions

399

Shares Held

87.1M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.88B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Intra Cellular Therapies, Inc. Transaction History